Daily non-political popular news in brief.

1 in 3 drivers under 'the limit' for alcohol still test positive for drugs

One in three drivers suspected of driving while "over the limit," but subsequently found to be below maximum permissible levels of alcohol, nevertheless tested positive for a range of drugs, reveals research in Injury Prevention.The findings prompt the authors to call for routine drugs testing in all drivers who are suspected of being over the limit for alcohol.

Read more »

Keywords: drivers, limit, alcohol, test, positive, drugs, driver, drug

« Previous | Next »

Similar news on "1 in 3 drivers under 'the limit' for alcohol still test positive for drugs":

1. HIV drug resistance risk in mothers reduced by combination of common drugs
   11-09-2007 · EurekAlert!
   Adding a single dose of two common anti-HIV drugs can prevent HIV-positive pregnant women from developing resistance to an entire class of drugs, potentially improving future treatment options.Providing tenofovir and emtricitabine with nevirapine during labor greatly reduces the extent of resistance to non-nucleoside reverse transcriptate inhibitors, such as nevirapine, which HIV-positive women take to lower the risk of mother-to-child transmission during childbirth.
   Similar news · Read more »
   
2. Bioabsorbable stent shows excellent performance
   03-24-2007 · EurekAlert!
   The use of slow-release drugs in stents (drug-eluting stents) has dramatically reduced restenosis rates after percutaneous coronary intervention. However, these permanent metal devices may impair coronary imaging, predispose patients to late stent thrombosis, prevent positive remodeling and hinder revascularization. A study presented today at the American College of Cardiology's Innovation in Intervention: i2Summit assesses the safety and performance of a bioabsorbable stent that, if effective, could eliminate several of the problems associated with metallic stents.
   Similar news · Read more »
   
3. MIT model could predict cells' response to drugs
   07-30-2007 · EurekAlert!
   MIT researchers have developed a model that could predict how cells will respond to targeted drug therapies. Models based on this approach could help doctors make better treatment choices and drug developers identify the ideal compound. In addition, the model could help test the effectiveness of drugs for a wide range of diseases, including cancer, arthirtis, and immune system disorders.
   Similar news · Read more »
   
4. No 'smoking' gun -- Research indicates teen marijuana use does not predict drug, alcohol abuse
   12-04-2006 · EurekAlert!
   Marijuana is not a "gateway" drug that predicts or eventually leads to substance abuse, suggests a 12-year University of Pittsburgh study. The study, which found that young men who chose to initiate their drug use with marijuana were no more likely to go on to abuse drugs or alcohol than those who smoked or drank first, calls into question the long-held belief that has shaped prevention efforts and governmental policy for six decades.
   Similar news · Read more »
   
5. Mouse Tests Predict Drug Response In Relapsing Pancreatic Cancer Patients
   10-12-2006 · ScienceDaily
   By slicing up bits of patient tumors and grafting them into mice, Johns Hopkins Kimmel Cancer Center specialists have figured out how to accurately 'test drive' chemotherapy drugs to learn in advance which drug treatments offer each individual pancreatic cancer patient the best therapeutic journey.
   Similar news · Read more »
   
6. Tiny tweezers and yeast help St. Jude show how cancer drug works
   07-09-2007 · EurekAlert!
   The annoying bulges of an over-wound telephone cord that shorten its reach and limit a caller's motion help to explain why drugs called camptothecins are so effective in killing cancer cells, according to investigators at St. Jude Children's Research Hospital and Delft University of Technology.
   Similar news · Read more »
   
7. New test predicts blood cancer's sensitivity to experimental cancer drug
   01-22-2007 · EurekAlert!
   A test developed by Dana-Farber Cancer Institute scientists is the first to identify which malignant blood cells are highly vulnerable to a promising type of experimental drugs that unleash pent-up "cell suicide" factors to destroy the cancer.
   Similar news · Read more »
   
8. Study finds flaws in cancer clinical trials
   02-01-2007 · EurekAlert!
   Cancer research and drug development are yielding more sophisticated candidate therapies, but investigators' methods to test them haven't kept pace, according to researchers at Memorial Sloan-Kettering Cancer Center. That could explain why so many experimental drugs fail in the final large and costly phase of testing, they say.
   Similar news · Read more »
   
9. Ignition locks reduce DWIs
   02-11-2008 · EurekAlert!
   Interlocks, breath-testing devices that prevent a vehicle's ignition from starting if the driver is above a preset blood alcohol limit, can dramatically reduce driving-while-impaired offenses among first-time offenders, a new study shows.
   Similar news · Read more »
   
10. Study found no drug interference with pomegranate juice
    08-20-2007 · EurekAlert!
    A study published in the Journal of Clinical Pharmacology finds that pomegranate juice does not interact with medication. Earlier studies suggested that, like grapefruit juice, pomegranate juice may interfere with metabolism of drugs by inhibiting CYP3A, an enzyme that allows the body to transform and eliminate a drug. This is the first study using human subjects to test the drug interactions of pomegranate juice, unlike prior studies which were conducted in vitro and in animals.
    Similar news · Read more »